Direxion Daily Energy Bull 2X Shares ETF
ERX
Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
United States Natural Gas
UNG
4
ProShares Ultra Materials
UYM
5
VanEck Oil Services ETF
OIH
HK Stock MarketDetailed Quotes
CH BIOTECH SER (08037)
- 0.740
- -0.010-1.33%
15min DelayMarket Closed Feb 6 16:05 CST
722.04MMarket Cap-4.81P/E (TTM)
0.780High0.740Low215.00KVolume0.740Open0.750Prev Close160.15KTurnover0.02%Turnover RatioLossP/E (Static)975.73MShares1.33052wk High3.02P/B722.04MFloat Cap0.34052wk Low--Dividend TTM975.73MShs Float3.985Historical High--Dividend LFY5.33%Range %0.114Historical Low0.744Avg Price5000Lot Size--Div Yield TTM--Div Yield LFY
08037 Stock Chart
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
08037 Orderflow
Unit: --
08037 Orderflow Trend
IntradayDayWeekMonth
No Data
CH BIOTECH SER (08037) News
Zhitong HK Stock Investment Diary | February 5
Hong Kong Stock Investment Diary | February 5, 2026
Zhitong HK Stock Investment Diary | February 2
Hong Kong Stock Investment Diary | February 2, 2026
China Biotech Services (08037) introduces strategic investor Mr. Gong Hongjia, ushering in a new chapter of industrial synergy and secondary growth.
On December 30, the board of China Biotech Services (08037) officially announced its intention to issue a 4-year convertible bond worth 35 million US dollars (approximately 272 million Hong Kong dollars) to Fuce Holdings, controlled by renowned investor Gong Hongjia, through special authorization.
China Biotech Services (08037): Boron Neutron Capture Therapy Device Successfully Achieves First Beam Output
China Biotech Services (08037) announced that the group, located in Boao Lecheng International Medical Tourism Pilot Zone in Hainan, China...
Express News | China Biotech Services - Outstanding Convertible Bonds Amount to $6 Mln
CH BIOTECH SER: INTERIM REPORT 2025
CH BIOTECH SER (08037) Stock Forum
Despite China Biotech Services Holdings' drop in share price and earnings, its high P/E ratio suggests investor optimism. However, weak earnings and slower growth could risk further price decline, challenging to justify without significant medium-term improvements.
Some China Biotech Services Holdings Limited (HKG:8037) Shareholders Look For Exit As Shares Take 30% Pounding 1
Substantial growth is required by the firm to validate its elevated P/E ratio, but the sustainability of its high stock price is dubious amid recent inconsistencies and dwindling profits. Its high P/E ratio and slower growth rate might contribute to a potential share price fall, risking shareholders and prospective investors.
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)